Phagos
Using bacteria's natural predator, the bacteriophage, we are able to overcome incurable and deadly infectious diseases.
Paris, Francephagos.org ↗
Total raised
€27M
€27,400,000
Funding rounds
2
Investors
13
distinct backers
Active since
2022-09
latest 2025-10
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood55
base rate 44% for Series A
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood12
base rate 12% (2+ rounds)
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-10-09 | Series A | €25M | Acurio Ventures,Capagro,CapHorn Invest,Citizen Capital,Demeter,Entrepreneurs First+3 more | View deal → |
| 2022-09-28 | Other | €2.4M | AgFunder,Entrepreneur First,Grant Aarons,Max Jamily | View deal → |
Investors
13Related news
- France’s Phagos raises €2.4m to replace antibiotics in animal farmssifted.eu · 2022-09
- tech.eu
Similar companies
same sector or country- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Mistral AI€3.5BFrance · AI
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- ContentSquare€1.3BFrance · Software